Augmenting a dynamic hip screw with a calcium sulfate/hydroxyapatite biomaterial.


Journal

Medical engineering & physics
ISSN: 1873-4030
Titre abrégé: Med Eng Phys
Pays: England
ID NLM: 9422753

Informations de publication

Date de publication:
06 2021
Historique:
received: 02 03 2021
revised: 30 04 2021
accepted: 09 05 2021
entrez: 25 6 2021
pubmed: 26 6 2021
medline: 9 9 2021
Statut: ppublish

Résumé

Internal fixation failure in hip fractures can lead to reoperation. Calcium sulfate/hydroxyapatite (CaS/HA) is a biomaterial that can be used for augmenting fracture fixation. We aimed to determine whether an injection of 2 ml CaS/HA increases the fixation of a dynamic hip screw inserted in synthetic and human trabecular bone. The study consists of two parts: 1) synthetic bone blocks (n = 74), with three subgroups: empty (cannulated screw, no injection), cannulated, and fenestrated; and 2) osteoporotic human femoral heads (n = 29), with the same subgroups. The heads were imaged using µCT. Bone volume fraction, insertion angle, and head diameter were measured. Pullout tests were performed and peak force, stiffness, and work were measured. The fenestrated group showed increases in pullout strength compared to no injection in the synthetic blocks. The cannulated group showed a higher pullout strength in low-density blocks. In the femoral heads, the variation was larger and there were no significant differences between groups. The bone volume fraction correlated with the peak force and work, and the insertion angle correlated with the stiffness. CaS/HA can improve the fixation of a dynamic hip screw. For clinical use, spreading of the material around the threads of the screw must be ensured.

Identifiants

pubmed: 34167704
pii: S1350-4533(21)00049-7
doi: 10.1016/j.medengphy.2021.05.006
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Bone Cements 0
Durapatite 91D9GV0Z28
Calcium Sulfate WAT0DDB505

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-109

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Joeri Kok (J)

Department of Biomedical Engineering, Lund University, Box 118, 22100 Lund, Sweden. Electronic address: joeri.kok@bme.lth.se.

Aurimas Širka (A)

Department of Orthopedics and Traumatology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Eiveniu ave.2, Kaunas, Lithuania. Electronic address: aurimas.sirka@lsmuni.lt.

Yang Liu (Y)

Department of Clinical Sciences, Orthopedics, Faculty of Medicine, Lund University, BMC C12, 22184 Lund, Sweden. Electronic address: liu.yang@med.lu.se.

Šarūnas Tarasevičius (Š)

Department of Orthopedics and Traumatology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Eiveniu ave.2, Kaunas, Lithuania. Electronic address: sarunas.tarasevicius@lsmuni.lt.

Juozas Belickas (J)

Department of Orthopedics and Traumatology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Eiveniu ave.2, Kaunas, Lithuania. Electronic address: juozasbelickas@gmail.com.

Magnus Tägil (M)

Department of Clinical Sciences, Orthopedics, Faculty of Medicine, Lund University, BMC C12, 22184 Lund, Sweden. Electronic address: magnus.tagil@med.lu.se.

Lars Lidgren (L)

Department of Clinical Sciences, Orthopedics, Faculty of Medicine, Lund University, BMC C12, 22184 Lund, Sweden. Electronic address: lars.lidgren@med.lu.se.

Hanna Isaksson (H)

Department of Biomedical Engineering, Lund University, Box 118, 22100 Lund, Sweden; Department of Clinical Sciences, Orthopedics, Faculty of Medicine, Lund University, BMC C12, 22184 Lund, Sweden. Electronic address: hanna.isaksson@bme.lth.se.

Deepak Bushan Raina (DB)

Department of Clinical Sciences, Orthopedics, Faculty of Medicine, Lund University, BMC C12, 22184 Lund, Sweden. Electronic address: deepak.raina@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH